Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
0.4340
+0.0740 (20.56%)
Mar 2, 2026, 4:00 PM EST
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $17.71 million as of March 3, 2026. Its market cap has decreased by -52.57% in one year.
Market Cap
17.71M
Enterprise Value
8.67M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.43
Market Cap Chart
Since May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from 165.19M to 17.71M, a decrease of -89.28%. That is a compound annual growth rate of -37.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 14.68M | -64.62% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -13.09% |
| May 7, 2021 | 165.19M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Finch Therapeutics Group | 21.28M |
| Oncotelic Therapeutics | 20.49M |
| Provectus Biopharmaceuticals | 19.75M |
| Zeo ScientifiX | 18.93M |
| Zenith Capital | 15.97M |
| Inhibitor Therapeutics | 13.81M |
| HOOKIPA Pharma | 13.50M |
| EOM Pharmaceuticals Holdings | 10.15M |